-
Walgreens Must Pay $300 Million In Opioid Case, Additional $50 Million If Sold Or Merged Before 2032
Monday, April 21, 2025 - 1:30pm | 591Read More...Walgreens Boots Alliance Inc (NASDAQ:WBA) on Monday said it will pay $300 million to resolve federal allegations that the company filled millions of invalid prescriptions for opioids and other controlled substances. Earlier this year, the U.S. Department of Justice filed a civil complaint against...
-
Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes
Wednesday, September 25, 2024 - 1:54pm | 576Read More...A new study has found that people with a history of opioid abuse who took Novo Nordisk‘s (NYSE:NVO) Ozempic weight loss drug were significantly less likely to overdose, adding to growing evidence suggesting that the drug, primarily used for diabetes and weight loss, could help manage drug...
-
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
Thursday, August 10, 2023 - 3:44pm | 687Read More...On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits related to the opioid crisis. The court also announced that it will hear a challenge to the settlement...
-
Fentanyl Fuels Ongoing US Drug Overdose Crisis: Over 109,000 Deaths Lost in 12 Months
Thursday, June 15, 2023 - 6:23am | 419Read More...Over 109,000 Americans lost their lives to drug overdoses in the 12 months ending in January 2023, representing a slight increase of 0.7% compared to the previous year. Fentanyl, a highly potent opioid, has played a significant role in the opioid crisis and the surge in drug overdoses in the...
-
Hope For Fibromyalgia Sufferers, Cannabis Linked To Improved Symptoms & Less Opioid Use In UK Study
Monday, May 29, 2023 - 3:30pm | 486Read More...People who live with the pain, nausea, anxiety, depression and other symptoms of fibromyalgia also live with the sad fact that there’s no cure and not a single drug to treat this condition that affects 3% to 5% of the world's population and 3.5 million people in ...
-
Department of Justice Accuses Rite Aid For Ignoring Obvious Signs Of Opioid Misuse
Tuesday, March 14, 2023 - 7:14am | 315Read More...The U.S. government reportedly sued Rite Aid Corp (NYSE: RAD), saying the company missed "red flags" as it illegally filled prescriptions for controlled substances, including opioids. The Justice Department joined a whistleblower lawsuit filed in 2019 by two pharmacists and a...
-
US Authority Plans Massive Expansion Of Medication Access To Combat Opioid Overdose Crisis
Tuesday, November 8, 2022 - 8:48am | 503Read More...Struggling with the opioid crisis, U.S. authorities plan to substantially expand access to medications tackling opioid addiction, such as methadone, buprenorphine, and naltrexone. In September, the federal government announced $1.5 billion in funding to tackle opioid overdoses, sanctions against...
-
Will Philly Get An Overdose Prevention Center? Talks Between Gov And Advocacy Group Mark Step In Right Direction
Tuesday, May 10, 2022 - 12:53pm | 353Read More...The nonprofit organization Safehouse has been in continuous communication with the U.S. Department of Justice (DOJ) to open a space where people can inject illegal opioids under medical supervision. In a recent press release, the organization stated that conversations continue to be productive....
-
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Monday, April 25, 2022 - 3:11pm | 442Read More...San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ: WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), AbbVie Inc's (...
-
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
Monday, April 4, 2022 - 2:09pm | 449Read More...West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: ABBV) Allergen accountable for causing a "tsunami" of opioid addiction in the...
-
CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report
Wednesday, March 30, 2022 - 2:38pm | 407Read More...Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic. CVS will shell out $484 million, Teva Pharmaceutical Industries Ltd...
-
Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters
Tuesday, March 22, 2022 - 2:33pm | 390Read More...Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over their roles in the opioid epidemic. According to the Reuters report, the...
-
Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?
Friday, February 25, 2022 - 4:18pm | 534Read More...Johnson & Johnson (NYSE: JNJ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible...
-
Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits
Friday, February 25, 2022 - 10:52am | 344Read More...Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and Johnson & Johnson (NYSE: JNJ) have agreed to finalize a proposed $26 billion settlement resolving claims by states and local...
-
Opiant's Multi-Dose Nasal Nalmefene Shows Safety, Tolerability In Opioid Overdose
Thursday, February 10, 2022 - 12:54pm | 282Read More...Opiant Pharmaceuticals Inc (NASDAQ: OPNT) announced topline results from a multi-dose pharmacokinetic (PK) study for OPNT003, nasal nalmefene, for opioid overdose. The crossover design study was conducted in 23 healthy subjects comparing the PK profile, safety, and...
















